Company Filing History:
Years Active: 1992
Title: The Innovations of Frederik S. Gronvald
Introduction
Frederik S. Gronvald, located in Vedbaek, Denmark, is a prominent inventor known for his contributions to the field of chemistry. With a focus on quinoxaline compounds, he has made notable advancements that hold the potential for various applications in pharmaceuticals and materials science.
Latest Patents
Gronvald holds a significant patent titled "Quinoxaline-2,3-dione compounds and their preparation and use." This invention includes 1-carboxyalkylquinoxaline-2,3(1H,4H)-dione compounds or their tautomeric forms. The chemical formula addresses R, which can represent hydrogen, C1-6-alkyl, including branched chains, or aralkyl, with 'n' ranging from 0 to 5. This patent reflects Gronvald's intricate understanding of chemical structures and their potential uses.
Career Highlights
Frederik S. Gronvald is affiliated with Novo Nordisk A/S, a leading global healthcare company known for its dedication to innovation in treatment and care, particularly in diabetes care. His work within this esteemed organization allows him to enhance his contributions to scientific research and development.
Collaborations
Throughout his career, Gronvald has collaborated with esteemed colleagues such as Anker S. Jorgensen and Carsten Enggaard Stidsen. Working alongside these talented individuals, Gronvald has been able to merge ideas and expertise, thereby fostering an environment of innovation.
Conclusion
Frederik S. Gronvald’s work exemplifies the spirit of innovation that drives progress in science and industry. His patent not only represents a personal achievement but also contributes to the larger community of researchers aiming to pave the way for new discoveries in the realm of chemical compounds.